FDA Inspection 1245336 — Xytex Laboratories

Xytex Laboratories — FEI 3003420280

The FDA completed an inspection of Xytex Laboratories on July 23, 2024 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 23, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Atlanta, GA (United States)